Improving Venous Thromboembolism Prophylaxis

NCT01304108 | Completed Phase 4

• 1 other identifier: 09-006359
• Study Type: interventional
• Target: 3,000
• Locations: 1 country
• Sites: 1

Brief Summary

Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for \"spreading\" to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%.

Conditions

Venous Thromboembolism; Delivery of Health Care; Quality Improvement

Keywords

Venous Thromboembolism; Delivery of Health Care; Quality Improvement; Evidence-Based Practice

Outcome Measures

Primary Outcomes (1)

• % of in patients with an appropriate VTE prophylaxis plan

  The investigators will measure the number of patients in a statistically valid random sample of hospitalized patients who have a VTE-prophylaxis plan consistent with current recommendations.

  Baseline to 1 month

Secondary Outcomes (1)

• Clinically significant complications of VTE-P anticoagulant therapy

  baseline to 1 month

Study Arms (3)

Order Set

EXPERIMENTAL

Insertion of VTE-P Order Set "tollgate" in all active admission and transfer orders.

Other: VTE-P Tollgate

Clinical Decision Support Pop-up

EXPERIMENTAL

Deploy rules-based pop-up that reminds ordering clinicians when patients do not have an active VTE-P plan.

Other: BLAZE Pop up

Usual Care

ACTIVE COMPARATOR

Usual care, without the experimental additions

Other: Usual Care

Interventions

VTE-P Tollgate OTHER

Add VTE-P tollgate order set that requires a decision regarding VTE-P for every patient admitted or transferred in our hospital system

Order Set

BLAZE Pop up OTHER

Develop and deploy a rules-based popup that reminds prescribers interfacing with the orders system when a patient does not have an active VTE-P plan.

Clinical Decision Support Pop-up

Usual Care OTHER

No addition to the baseline system for care

Usual Care

Eligibility Criteria

• Age: 17 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Inpatients with age \> 17 years old

You may not qualify if:

• Outpatients
• Inpatients with age less than or equal to 17 years old

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

Thromboembolism; Embolism and Thrombosis; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Timothy Morgenthaler, MD

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 4
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: July 9, 2010
• First Posted: February 25, 2011
• Study Start: January 1, 2009
• Primary Completion: May 1, 2010
• Study Completion: May 1, 2010
• Last Updated: February 25, 2011

Record last verified: 2011-02

Locations

US (1)